Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene
about
The deletion of 14 amino acids in the seventh transmembrane domain of a naturally occurring calcitonin receptor isoform alters ligand binding and selectively abolishes coupling to phospholipase CThe rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate productionClassification between normal and tumor tissues based on the pair-wise gene expression ratioThe human secretin receptor gene: genomic organization and promoter characterizationStructure of the human VIPR2 gene for vasoactive intestinal peptide receptor type 2VPAC receptors for VIP and PACAPVasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor IkarosIdentification of a glucose response element in the promoter of the rat glucagon receptor gene.The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20The expression of vasoactive intestinal peptide receptor 1 is negatively modulated by microRNA 525-5p.Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.Expression analysis of PAC1-R and PACAP genes in zebrafish embryos.Vasoactive intestinal peptide receptor 1 is downregulated during expansion of antigen-specific CD8 T cells following primary and secondary Listeria monocytogenes infections.Vasoactive intestinal peptide signaling axis in human leukemia.Characterisation of the mouse vasoactive intestinal peptide receptor type 2 gene, Vipr2, and identification of a polymorphic LINE-1-like sequence that confers altered promoter activity.Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometryPituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomasPituitary adenylate cyclase-activating polypeptide inhibits transforming growth factor-beta1-induced apoptosis in a human pituitary adenoma cell line.Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo.VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells.Developmental upregulation of human parathyroid hormone (PTH)/PTH-related peptide receptor gene expression from conserved and human-specific promoters.Molecular cloning and characterization of two pig vasoactive intestinal polypeptide receptors (VPAC1-R and VPAC2-R).Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.Extragastrointestinal functions and transcriptional regulation of secretin and secretin receptors.Pathogenesis of achalasia cardia.Investigation of the possible functions of PACAP in human trophoblast cells.Sp1/Sp3 binding is associated with cell-specific expression of the glucose-dependent insulinotropic polypeptide receptor gene.CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis.Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine.A natural variant type II G protein-coupled receptor for vasoactive intestinal peptide with altered function.A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines.Cloning and characterization of the 5'-flanking region of the human growth hormone-releasing hormone receptor gene.Activation of cAMP-dependent C1- currents in guinea-pig paneth cells without relevant evidence for CFTR expression.Vasoactive intestinal peptide (VIP)1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide.Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases.Vasoactive intestinal peptide suppresses macrophage-mediated inflammation by downregulating interleukin-17A expression via PKA- and PKC-dependent pathways.
P2860
Q24322803-9D824634-71CC-47DF-868E-83C5693C9937Q24685090-47313636-F45C-4AC9-B11F-A2656B35196BQ24805850-58E9DA74-6D8A-4D7B-A1B0-D69E0EDE6DBFQ28141416-8BF10387-5B33-421D-B0CA-60CC8877BE64Q28144174-D9F32EDB-2406-4965-A63D-504D88B651A7Q28203262-131CF2A3-20DE-4A49-8E24-A3892AB5CDB7Q28216731-CA107C84-B352-4E5E-8A32-5906A873BE96Q30654544-CDAA5F62-DFC9-46FC-BABA-F404ADC02508Q30859120-CECD71DE-6E56-476F-B41C-2C787533407BQ33656489-B3E21D65-D4B3-463B-B103-89D662BEBE63Q33950137-914B9AAD-5535-48DA-B08F-66106FBB0D56Q34254582-9CC74162-2FA9-46A0-AAD9-555052CB7C0EQ34479009-903E7271-DF64-4BAE-B871-52A21B5D02BFQ34975674-534AF610-8A4F-4631-B2F5-C366B626C240Q35103939-71E0A555-64AC-4FE2-9077-37C43C6DD5BAQ35648983-FF480CF3-7281-4F7D-82D4-9E44E1E91333Q35740179-CBC730FD-11A7-4039-A5B9-EE80E84A714BQ35786043-07C740FD-2CA6-4A06-B993-DAB6A1CEE900Q35787965-D07360A0-5911-4FDC-9C2C-1800B81B5FA2Q36153216-524DF986-34EC-422D-930B-E76E6E6CF1DCQ36734495-8BF9BF97-6B33-48D7-8282-6C85B9FB51A4Q37230862-CD01650C-8095-4CC5-A9FF-2902855F8D8AQ37384867-54242D4E-B007-4A82-ADC3-49F1E2BA9785Q37667552-AD2ED411-149A-4122-9425-B7F400961FD4Q37696458-3A98C066-B27C-45EB-849D-F0135A53B1A3Q37851160-739F3EAC-A93B-4495-8F8E-A10442A84CB0Q38026029-5DDE7E78-C25E-43EC-99C7-33F3CF74F4F9Q38990442-1AA2DFBB-819F-447D-ABBB-C3E069A3D85BQ40332131-682DA852-F2DB-4E28-90A1-01DE7EF9085AQ40432095-F4B565C7-7830-4C36-AFDB-D4BA971AAC0FQ40458253-F7B54247-BBB3-4DA9-A216-EA0ED4AE81B7Q40526986-C9AE98C7-835B-48D1-B6AC-949FA3240216Q40775461-086C998F-9D91-422F-AE87-2B3E7869AE56Q40960156-4ECD549C-A674-47DD-BDC6-32BA97FB4932Q41003224-5ABECAF3-AB51-494F-BD08-DEDAE9AC0BCEQ41197334-EF3E8D6D-95A0-4923-A758-CA9C8B947B23Q47921833-D9384F9D-E68B-4A9C-8458-1288D52850F5Q53516273-C6FAFBAE-2D21-42A9-A44C-287A537EB481
P2860
Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Structure, expression, and chr ...... testinal peptide receptor gene
@ast
Structure, expression, and chr ...... testinal peptide receptor gene
@en
Structure, expression, and chr ...... testinal peptide receptor gene
@nl
type
label
Structure, expression, and chr ...... testinal peptide receptor gene
@ast
Structure, expression, and chr ...... testinal peptide receptor gene
@en
Structure, expression, and chr ...... testinal peptide receptor gene
@nl
prefLabel
Structure, expression, and chr ...... testinal peptide receptor gene
@ast
Structure, expression, and chr ...... testinal peptide receptor gene
@en
Structure, expression, and chr ...... testinal peptide receptor gene
@nl
P2093
P2860
P356
P1476
Structure, expression, and chr ...... testinal peptide receptor gene
@en
P2093
E J Goetzl
M C Cheung
S P Sreedharan
P2860
P304
P356
10.1073/PNAS.92.7.2939
P407
P577
1995-03-28T00:00:00Z